![[img]](https://epub.uni-regensburg.de/style/images/fileicons/application_pdf.png) | Lizenz: Allianz- bzw. Nationallizenz PDF - Veröffentlichte Version (95kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-376463
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.37646
Zusammenfassung
Background: Since 2010, combination therapy with gemcitabine and cisplatin is the standard treatment for patients with biliary tract cancer (BTC) based on the ABC-02 trial. However, treatment after first-line progression is less clearly defined. We therefore retrospectively analyzed the efficacy of a 3-drug chemotherapy regimen in patients with advanced BTC. Methods: Patients with advanced BTC ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik